¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fetal blood loss from placenta"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® blood clotting, blood coagulation ÇÑ±Û Ç÷¾×ÀÀ°í
¼³¸í   
  »ç¶÷ÀÇ ¸ö¿¡ »óó°¡ ³ª¼­ ÃâÇ÷ÀÌ ÀÖÀ» °æ¿ì¿¡ À̰ÍÀ» ¸·°í ÇǸ¦ ´õÀ̻󠳪Áö ¾Ê°Ô Çϴ °ÍÀ» ÁöÇ÷À̶ó°í ÇÑ´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡´Â Å©°Ô µÎ °¡Áö ´Ü°è°¡ ÀÖ´Ù. Ã¹¹øÂ° ´Ü°è´Â Ç÷¼ÒÆÇµéÀÌ »óó°¡ ³ª¼­ ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¸¦ ¸·´Â °ÍÀÌ´Ù. ÀÌ·¸°Ô Çϸ頿켱 Ç÷°üÀÇ ¼Õ»óºÎÀ§·Î ºÎÅÍ Çǰ¡ ³ª¿À´Â °ÍÀ» ¸·À» ¼ö°¡ ÀÖ´Ù. ´ÙÀ½ÀÇ ´Ü°è´Â »ó󸦠¸·°í Àִ Ç÷¼ÒÆÇÀ§¿¡ ¿©·¯ °¡Áö ¹°ÁúµéÀÌ ÀÛ¿ëÇØ¼­ ´õ¿í ´Ü´ÜÇϰԠÇÏ¿© »óó°¡ ³­ Ç÷°ü¿¡¼­ Çǰ¡ »õ´Â °ÍÀ» ¿µ±¸È÷ ¸·´Â °ÍÀÌ´Ù. ½±°Ô ¸»Çϸé Ç÷¼ÒÆÇÀº º®µ¹¿¡ ÇØ´çÇϴ °ÍÀÌ°í µÎ¹øÂ° °úÁ¤¿¡ Âü¿©Çϴ ¹°ÁúµéÀº ½Ã¸àÆ®¿¡ ÇØ´çÇϴ °ÍÀÌ´Ù. ÀÌ µÎ °úÁ¤ÀÌ ¿ÏÀüÇÒ °æ¿ì¿¡ ÁöÇ÷ÀÌ ¼øÁ¶·Ó°Ô ÀϾ´Ù. Ç÷¾×ÀÀ°í¶õ µÎ¹øÂ° ´Ü°è¸¦ ÁöĪÇϴ ¸»·Î½á ¸Å¿ì º¹ÀâÇÑ ´Ü°è¸¦ °ÅÄ¡´Â ¹ÝÀÀÀ¸·Î ¸¶Áö¸· ´Ü°è´Â ¼¶À¯¼Ò¶ó´Â ¹°ÁúÀÌ ¸¸µé¾îÁ®¼­ ÀÌ ¹°ÁúÀÌ Ç÷¼ÒÆÇ°ú ±× ¿ÜÀÇ ¼¼Æ÷¸¦ ´Ü´ÜÇϰԠ°íÁ¤½ÃÄÑ Çǰ¡ »óó³­ Ç÷°üÀ¸·Î »õ´Â °ÍÀ» ¸·´Â´Ù. À̰ÍÀ» °¡Àå °£´ÜÈ÷ ¼³¸íÇÏÀÚ¸é Å©°Ô ´ÙÀ½°ú °°Àº 3°¡Áö ´Ü°è·Î ÀÌ·ç¾îÁø´Ù.
  
  Ã¹¹øÂ° ´Ü°è´Â Ç÷°ü¼Õ»ó¿¡ ÀÇÇØ¼­ ÇÁ·ÎÆ®·Òºó È°¼ºÁ¦¶ó´Â °ÍÀÌ ¸¸µé¾îÁö´Â ´Ü°èÀÌ´Ù.
  
  µÎ¹øÂ° ´Ü°è´Â ÀÌ ÇÁ·ÎÆ®·Òºó È°¼ºÁ¦¶ó´Â ¹°Áú¿¡ ÀÇÇØ¼­ Ç÷¾×¼Ó¿¡ Àִ ÇÁ·ÎÆ®·ÒºóÀ̶ó´Â ¹°ÁúÀÌ Æ®·ÒºóÀ̶ó´Â ¹°Áú·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù.
  
  ¼¼¹øÂ° ´Ü°è´Â Æ®·ÒºóÀ̶ó´Â ¹°Áú¿¡ ÀÇÇØ¼­ ¼¶À¯¼Ò¿øÀ̶ó´Â ¹°ÁúÀÌ ¼¶À¯¼ÒÀ¸·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù.
¿µ¹® placenta accreta ÇÑ±Û À¯ÂøÅ¹Ý
¼³¸í   
  Å¹ݠºÐ¸®°¡ ÀϾ´Â ÇظéÅ»¶ô¸·ÀÌ ¾ø°Å³ª ºÎÁ·ÇÑ ºÎÀ§¿¡ Å¹ÝÀÌ Âø»óµÇ¾î¼­ Çϳª ÀÌ»óÀǠŹݿ±(cotyledon)ÀÌ, °áÇÔÀÌ Àִ ±âÀú Å»¶ô¸·À̳ª ÀڱñÙÃþ°ú ´Ü´ÜÈ÷ ºÙ¾î Àִ °æ¿ì¸¦ ¸»ÇÑ´Ù.
¿µ¹® placenta previa ÇÑ±Û ÀüġŹÝ
¼³¸í   
  Å¹ÝÀÌ ÀÚ±ÃÃⱸÀÇ ÀüºÎ È¤Àº ÀϺκÐÀ» ¸·¾Æ Å¾ư¡ ³ª¿ÀÁö ¸øÇϰԠµÇ´Â Å¹ÝÀÇ À§Ä¡ÀÌ»óÀ» ¸»ÇÑ´Ù. ÀÌ °æ¿ì Áø´ÜÀº ÃÊÀ½ÆÄÃÔ¿µÀ¸·Î Çϸç, Ä¡·á´Â Á¦¿ÕÀý°³¼ú¿¡ ÀÇÇÑ Ãâ»êÀÓ.
¿µ¹® placenta ÇÑ±Û Å¹Ý
¼³¸í   
  Æ÷À¯µ¿¹°¿¡¼­ ÀÓ½ÅÇÏ¿´À» ¶§, Å¾ƿ͠¸ðü »çÀÌÀÇ °¡½º ¹× ¹°Áú ±³È¯°ú ÀӽŠÀ¯Áö¸¦ À§ÇÑ ³»ºÐºñ¹°ÁúÀ» ºÐºñÇϴ ±â°üÀ¸·Î ¸ðüÀÇ Àڱà³»¿¡ À§Ä¡ÇÑ´Ù. ºÐ¸¸ ½Ã Å¹ݵµ ¹ÛÀ¸·Î ¶³¾îÁ® ³ª¿À°Ô µÇ¸ç, Å¾ƿʹ ÅÈÁٷΠÀ̾îÁ® ÀÖ´Ù.
¿µ¹® fetal monitoring ÇÑ±Û Å¾ư¨½Ã
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù.
  
  1. ºÐ¸¸Àü Å¾ư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù.
  
    1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù.
  
    2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±×°÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý.
  
    3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱüӿ¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
  
    4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ Å¾ƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼­ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ Å¾ư¡ ¹ÝÀÀÀ» Çؼ­ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù.
  
    5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» Çؼ­ ½É¹Ú¼ö°¡ º¯È­ÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀÌ´Ù.
  
  2. ºÐ¸¸Áߠžư¨½Ã
  
  ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ °Ç°­»óŸ¦ °¨½ÃÇϴ °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ Å¾ư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀǠžư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù.
  
    1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù.
  
    2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼­ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼­ Å¾ÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁַΠ°Ë»ç¸¦ ÇàÇϴ Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal placenta
    žÆÅ¹Ý
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®, Çã¿ëÇ÷¾×»ó½Ç·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • conductive hearing loss
    ÀüÀ½³­Ã», Àüµµ³­Ã»
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • functional hearing loss
    ±â´É³­Ã»
  • familial progressive hearing loss
    °¡Á·¼ºÁøÇ೭û
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
  • heat loss
    ¿­¼Õ½Ç
  • high velocity signal loss
    °í¼Ó½ÅÈ£¼Ò½Ç
  • ionization loss
    ÀÌ¿ÂÈ­¼Õ½Ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • loss
    »ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • placenta previa totalis
    ¿ÏÀüÀüġŹÝ, ¿ÏÀü¸ñŹÝ
  • placenta previa
    ÀüġŹÝ, ¸ñŹÝ
  • placenta accreta
    À¯ÂøÅ¹Ý
  • placenta
    ŹÝ
  • velamentous placenta
    ÇǸ·Å¹Ý
  • loss of short-term variability
    ´Ü±âº¯µ¿¼Ò½Ç
  • fetal anemia
    žƺóÇ÷
  • fetal head compression
    žƸӸ®¾Ð¹Ú
  • severe fetal distress
    ½ÉÇÑžÆÀý¹Ú°¡»ç, ½ÉÇÑžưíÅë
  • fetal
    žÆ-
  • fetal hypoxia
    žÆÀú»ê¼ÒÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal placenta
    žÆÃøÅ¹Ý
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • condensed milk conductive hearing loss
    ³óÃà¿ìÀ¯ÀüµµÃ»°¢¼Ò½Ç
  • conductive hearing loss
    Àüµµ³­Ã»
  • conductive hearing loss
    ÀüÀ½¼º³­Ã»
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
  • familial progressive hearing loss
    °¡Á·ÁøÇ೭û
  • functional hearing loss
    ±â´É³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç
  • heat loss
    ¿­¼Õ½Ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • F hemoglobin fetal
    žƼº(÷Ãä®àõ) Çì¸ð±Û·Îºó
  • FECG= fetal electrocardiogram
    ÅÂ¾Æ½É Àüµµ.
  • Fetal circulation
    žƼøÈ¯(÷Ãä®âàü»)
  • Fetal hemoglobin
    žÆÇ÷»ö¼Ò(÷Ãä®úìßäáÈ)
  • Fetal respiration
    žÆÈ£Èí(÷Ãä®û¼ýå)
  • Fetal thyroid-stimulating hormone
    žư©»ó¼±ÀÚ±Ø(÷Ãä®Ë£ßÒàÍí©Ð½)È£¸£¸ó
  • antigen, fetal
    žÆÇ׿ø
  • antigen,fetal
    žƼº(÷Ãä®àõ)
  • antigen,fetal tumor-associated
    žÆÁ¾¾ç °ü·Ã¼º(÷Ãä®ðþåË Î¼Ö¤àõ)
  • hemoglobin, fetal =HbF
    žƼº Çì¸ð±Û·Îºó.
  • hemoglobin, fetal =HbF
    žƼºÇì¸ð±Û·Îºó
  • huma immunodeficiency virus,fetal acquisition of
    Å»ýȹµæ(÷ÃßæüòÔð)
  • initial fetal period
    žÆÃʱâ
  • persistence of fetal form (lobated kidney)
    žÆÇüÅÂÁ¸¼Ó (ºÐ¿±ÄáÆÏ)
  • prenatal respiration =fetal r.
    žÆÈ£Èí(÷Ãä®û¼ýå).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal placenta
    žÆÃøÅ¹Ý(¡­ö°÷ÃÚï).
  • blood loss
    ½ÇÇ÷
  • blood loss
    ½ÇÇ÷(ã÷úì).
  • blood loss
    ½ÇÇ÷(½ÇÇ÷).
  • blood loss
    ½ÇÇ÷(ã÷úì)
  • blood loss
    ½ÇÇ÷(ã÷úì)
  • fetal blood
    žÆÇ÷(÷Ãä®úì).
  • blood alcohol level = blood alcohol concentration
    Ç÷Áß¾ËÄڿóóµµ
  • abrasion loss
    ¸¶¸ê·®(¸¶¸ê¾ç).
  • audiometric hearing loss
    û·Â¼Õ½Ç
  • autoimmune disease,t-supperssor function loss
    T-¾ïÁ¦¼¼Æ÷ ±â´É»ó½Ç(¡­åäð¤á¬øàѦÒößÃã÷)
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell loss factor
    ¼¼Æ÷¼Ò½Ç°è¼ö
  • central hearing loss
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã».
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fetal inclusion
    ºÀÀÔžÆ
    [¿¾ ¿ë¾î] ºÀÀÔ±âÇüžÆ
  • Vitamin deficiency (Fetal osteodystrophy)
    ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
    [¿¾ ¿ë¾î] ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
  • Fetal period
    žƱâ
    [¿¾ ¿ë¾î] žƱâ
  • Defect of fetal membrane
    žƸ·°áÇÔ
    [¿¾ ¿ë¾î] Ÿ·°áÇÔ
  • Fetal part
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Fetal parts
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Definitive fetal period
    žƿϼº±â
    [¿¾ ¿ë¾î] žƿϼº±â
  • Fetal cotyledon
    žÆÂÊŹݿ±
    [¿¾ ¿ë¾î] žÆÃøÅ¹ݿ±
  • Initial fetal period
    žÆÃʱâ
    [¿¾ ¿ë¾î] žÆÀü±â
  • Fetal lung
    žÆÇãÆÄ
    [¿¾ ¿ë¾î] ÅÂ¾ÆÆó
  • Blood vessels of retina
    ¸Á¸·Ç÷°ü
    [¿¾ ¿ë¾î] ¸Á¸·Ç÷°ü
  • Blood capillary
    ¸ð¼¼Ç÷°ü
    [¿¾ ¿ë¾î] ¸ð¼¼Ç÷°ü
  • Renal blood vessel
    ÄáÆÏÇ÷°ü
    [¿¾ ¿ë¾î] ½ÅÀåÇ÷°ü
  • Cartilage canal of blood vessel
    Ç÷°ü¿¬°ñ°ü
    [¿¾ ¿ë¾î] Ç÷°ü¿¬°ñ°ü
  • Thrombocyte [Blood platelet]
    Ç÷¼ÒÆÇ
    [¿¾ ¿ë¾î] Ç÷¼ÒÆÇ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood film
    Ç÷¾×µµ¸»
  • blood nematode
    Ç÷°ü¼±Ãæ
  • blood protozoa
    Ç÷¾×¿øÃæ
  • blood-sucking flies
    ÈíÇ÷ÆÄ¸®·ù
  • oriental blood fluke(=Schistosoma japonicum)
    ÀϺ»ÁÖÇ÷ÈíÃæ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆ(÷Ãä®) È÷¸ð±Û·Îºó
  • placenta
    ŹÝ(÷ÃÚï)
  • coincidence loss
    µ¿½Ã¼Õ½Ç(ÔÒãÁáßã÷)
  • counting loss
    "°èÃø ¼Õ½Ç(ͪö´áßã÷), (ÔÒ) coincidence loss"
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
  • blood-brain barrier
    Ç÷³ú À庮(úìÒàî¡Ûú)
  • blood-cerebrospinal fluid barrier
    Ç÷³úô¼ö¾× À庮(úìÒàô±âÐäûî¡Ûú)
  • blood plasma
    Ç÷Àå(úìíì)
  • blood platelet
    Ç÷¼ÒÆÇ(úìá³÷ù)
  • blood serum
    Ç÷û(úìôè)
  • blood sugar
    Ç÷´ç(úìÓØ)
  • blood urea nitrogen
    Ç÷´¢¼ÒÁú¼Ò(úìÒãáÈòòáÈ)
  • defibrinated blood
    Å»¼¶À¯ Ç÷¾×(÷­àéë«úìäû)
  • extrinsic blood coagulation
    ¿ÜÀÎ Ç÷¾×ÀÀ°í (èâì×úìäûëêͳ)
  • intrinsic blood coagulation
    ³»ÀÎ Ç÷¾×ÀÀ°í(Ò®ì×úìäûëêͳ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • horseshoe placenta
    ¸¶Á¦»óŹÝ
  • placenta
    ŹÝ
  • placenta previa
    ÀüġŹÝ
  • retained placenta
    ÀÜ·ùŹÝ
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã»
  • energy loss
    ¿¡³ÊÁö¼Õ½Ç
  • fetal
    žÆÀÇ, ų»ÀÇ
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • fetal death
    žƻç¸Á
  • fetal distress syndrome
    žưï¶õÁõÈıº
  • fetal hemoglobin
    žƼºÇì¸ð±Û·Îºó, žƼºÇ÷»ö¼Ò
  • fetal position
    ÅÂÀ§
  • fetal sac
    ų¶
  • hearing loss
    û°¢¼Õ½Ç
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
CBV capillary blood cell velocity; catheter balloon valvuloplasty; central blood volume; cerebral blood ...
CBL circulating blood lymphocytes; chronic blood loss; cord blood leukocytes
CBF capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPCM Human placenta-conditioned medium
PlGF Placenta Growth Factor
PP14 Placenta protein 14
EBL Estimated blood loss
MBL Menstrual blood loss
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • P50.2
    Fetal blood loss from placenta
    ŹÝÀ¸·Î ÀÎÇÑ ÅÂ¾Æ ½ÇÇ÷
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood loss
    ½ÇÇ÷
  • ablatio placenta
    ÅÂ¹Ý Á¶±â ¹Ú¸®
    ÀӽŠÈĹݱ⿡ ÀϾ´Â ÅÂ¹Ý ºÎÂøºÎÀÇ ¹Ú¸®. È®½ÇÇÑ ¿øÀÎÀº ¸ð¸£Áö¸¸, ÀӽŠÁßµ¶Áõ°ú ƯÈ÷ ´Ü¹é´¢¸¦ ¼ö¹ÝÇÏ´Â ÀÏÀÌ ¸¹´Ù. º¹ºÎÀÇ ÅëÁõ, Àڱà ±ÙÀ°ÀÇ °­Á÷¼º ¼öÃà, ÃâÇ÷ÀÌ 3°¡Áö ÁÖ¿äÇÑ Áõ»óÀ̸ç, žÆÀÇ ½ÉÀåÀ½Àº ºÒ±ÔÄ¢ÇØÁö°í, ÁßÁõÀÎ °æ¿ì¿¡´Â ų»¿¡¼­ »ç¸ÁÇÑ´Ù. ÀÓ»ó Áõ»óÀº ÅÂ¹Ý ¹Ú¸®ÀÇ Á¤µµ¿¡ µû¶ó ´Ù¸£¸ç, ¸ð¾ÆÀÇ ¿¹ÈÄ¿Í ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù. ÇÕº´ÁõÀ¸·Î¼­ ÃâÇ÷¼º ¼îÅ©, Ç÷¾× ÀÀ°í ±âÀüÀÇ Àå¾Ö µîÀÌ ÀÖ´Ù. Ä¡·á´Â Àü½Å »óŸ¦ °³¼±ÇÏ¿© µÉ ¼ö ÀÖÀ¸¸é »¡¸® ºÐ¸¸À» Á¾·á½ÃŰ´Â °ÍÀÌ´Ù.
  • abnormal fetal presentation
    ÀÌ»ó ÅÂÀ§
    žÆÀÇ À§Ä¡°¡ ºñÁ¤»óÀûÀÎ °Í.
  • accessory placenta
    ºÎŹÝ
    ÅÂ¹Ý ½ÇÁú°ú ºÐ¸®µÇ¾î À¶¸ðÇ÷°üÀ¸·ÎºÎÅÍ Ç÷¾×À» °ø±Þ¹Þ´Â ŹÝÁ¶Á÷ÀÌ Á¸ÀçÇÏ´Â °ÍÀ» ¸»Çϸç, ÀÌ¿­Å¹ÝÀº ÅÂ¹Ý ½ÇÁúÀÌ ºñ½ÁÇÑ Å©±âÀÇ µÎ °³ÀÇ ºÐ¸®µÈ ¼Ò¿±À¸·Î ±¸¼ºµÈ °ÍÀ» °¡¸®Å²´Ù.
  • adherent placenta
    ºÎÂø ŹÝ
  • capsular placenta
    ÇÇÆ÷Å»¶ô¸· ŹÝ
  • chorioamniotic placenta
    À¶¸ð ¾ç¸· ŹÝ
  • fetal alcohol
    ÅÂ¾Æ ¾ËÄÝ
  • fetal antigen
    ÅÂ¾Æ Ç׿ø
    Á¾¾ç °ü·Ã Ç׿øÀÇ ÀÏÁ¾, Å»ý±â Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö¸¸, Á¤»óÀûÀÎ ºÐÈ­¸¦ ¹âÀº Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö ¾Ê°Å³ª ±ØÈ÷ ¹Ì·® Á¸ÀçÇϰųª ÇÑ´Ù.
  • fetal cartilage
    ų» ¿¬°ñ
  • fetal cretinism
    ÅÂ¾Æ °©»ó¼± ±â´É ÀúÇÏÁõ
  • fetal distress syndrome
    ÅÂ¾Æ °ï¶õ ÁõÈıº
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó
  • fetal liver cell
    ÅÂ¾Æ °£ ¼¼Æ÷
    ÅÂ¾Æ °£ ¼¼Æ÷, Á¶Ç÷ stem ¼¼Æ÷°¡ µé¾î ÀÖ°í, µû¶ó¼­ °¢Á¾ ¸é¿ª ¼¼Æ÷ÀÇ Àü±¸ ¼¼Æ÷¸¦ Æ÷ÇÔÇÑ´Ù. ÃÖ±Ù ¸é¿ªºÎÀüÀÇ Áúȯ, ¿¹¸¦ µé¸é ÁßÁñ º¹ÇÕ ¸é¿ª ºÎÀüÁõ¿¡¼­´Â Á¶Á÷ ÀûÇÕ °ñ¼ö¸¦ ¾òÁö ¸øÇÏ´Â °æ¿ì, 8ÁÖ ÀÌÀüÀÇ ÅÂ¾Æ °£¼¼Æ÷ÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁ® Àå±â°£ÀÇ »ýÁ¸ ¿¹¸¦ º¼ ¼ö ÀÖ´Ù.
  • fetal placental-maternal interrelation
    žÆ-ŹÝ-¸ðü »óÈ£ °ü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
fetal Of or pertaining to a foetus, pertaining to in utero development after the embryonic period.
(18 Nov 1997)
blood loss, surgical Loss of blood during surgery.
(12 Dec 1998)
alveolar bone loss The resorption of bone in the supporting structures of the maxilla or mandible as a result of periodontal disease.
(12 Dec 1998)
axon loss polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
Parallel Electron Energy Loss Spectroscopy <technique> Electron energy loss spectroscopy analyses the inelastically scattered electrons present in the beam after it has been transmitted through the sample. An electron energy loss spectrum typically consists of a monatomic decreasing background on which are superimposed a number of peaks. Each peak is characteristic of the scattering process that has occurred in the sample. The peaks can be used to obtain information about the chemical composition and electronic structure of the sample. Electron energy loss spectra are acquired typically in a magnetic sector spectrometer located under the camera chamber of the transmission electron microscope. Spatial resolution is typically limited by the minimum probe diameter of the microscope. Electron energy loss spectroscopy tends to be complimentary to EDS in that it can be used to analyse very thin samples of low Z materials.
Acronym: PEELS
(05 Aug 1998)
periodontal attachment loss Loss or destruction of periodontal tissue caused by periodontitis or other destructive periodontal diseases or by injury during instrumentation. Attachment refers to the periodontal ligament which attaches to the alveolar bone. It has been hypothesised that treatment of the underlying periodontal disease and the seeding of periodontal ligament cells enable the creating of new attachment.
(12 Dec 1998)
water loss, insensible Loss of water by diffusion through the skin and by evaporation from the respiratory tract. It is so called because we do not know that we are actually losing water at the time that it is leaving the body. (guyton, textbook of medical physiology, 8th ed, p274)
(12 Dec 1998)
weight loss Decrease in existing body weight.
(12 Dec 1998)
conductive hearing loss <otolaryngology> A form of deafness that results from a blockage of the ear canal or dysfunction of the ossicles or eardrum (sound collecting apparatus).
In conductive hearing loss the auditory nerve is normal, but there exists a physical problem with the sound collecting apparatus.
(05 Jan 1998)
hair loss Hair loss may be associated with aging, hormones (androgens) or genetic predisposition. The pattern of baldness in women is different from that of men. In women there is thinning of the hair all over the scalp, but the frontal hairline is maintained. The hair loss is usually permanent. Treatment has been successful with topical minoxidil in some cases.
(13 Nov 1997)
hearing loss, bilateral Partial hearing loss in both ears.
(12 Dec 1998)
hearing loss, central Hearing loss due to central nervous system disease, anywhere in the auditory pathways from the cochlear nucleus of the pons to the auditory cortex.
(12 Dec 1998)
hearing loss, conductive Hearing loss due to interference with the acoustic transmission of sound to the cochlea. The interference is in the outer or middle ear.
(12 Dec 1998)
hearing loss, functional Hearing loss without a physical basis.
(12 Dec 1998)
hearing loss, high-frequency Hearing loss in frequencies above 1000 hertz.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • placenta
    ŹÝ
  • fetal
    žÆÀÇ
  • fetal hemoglobin
    žƼº Ç÷»ö¼Ò;žƼº Çì¸ð±Û·Îºó
  • fetal position
    žÆÇü ÀÚ¼¼
  • be at a loss
    ºÒÈ®½ÇÇÑ »óÅ¿¡ ÀÖ´Ù
  • loss
    ºÐ½Ç
  • consequential loss insurance
    °£Á¢ ¼ÕÇØ º¸Çè
  • dead loss
    Àü¼Õ
  • friction loss
    ¸¶Âû¼Õ½Ç
  • loss
    ¼Õ½Ç;»ó½Ç;¼ÕÇØ;½ÇÆÐ;ÆÐ¹è;¼Ò¸ð;at a ~ °ï¶õÇÏ¿©;¾î¿ ÁÙ ¸ô¶ó¼­
  • loss leader
    Ư¸Åǰ
  • blood
    ÇÇ(Ç÷¾×),Ç÷Åë,Ãâ»ý
  • bad blood
    ³ª»Û °¨Á¤;Áõ¿À
  • blood
    ÇÇ;Ç÷¾×;Ç÷Åë;¼øÁ¾;»ìÀ°
  • blood bank
    Ç÷¾×ÀºÇà
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á